Benefits associated with lowered serum DHT levels after 5 α-reductase inhibitor (5AR-I)
therapy in men have contributed to a misconception that circulating DHT levels are an …

Background Testosterone deficiency (TD) is an increasingly common problem with
significant health implications, but its diagnosis and management can be challenging. Aim …

Introduction Testosterone deficiency (TD), also known as hypogonadism, is a condition
affecting a substantial proportion of men as they age. The diagnosis and management of TD …

ABSTRACT Introduction In 2014, the International Society for Sexual Medicine (ISSM)
convened a panel of experts to develop an evidence‐based process of care for the …

Aim The goal of this study was to determine if long‐term testosterone (T) therapy in men with
hypogonadism, henceforth referred to as testosterone deficiency (TD), ameliorates or …

Background Experimental and clinical evidence implicates testosterone in the aetiology of
prostate cancer. Variation across the normal range of circulating free testosterone …

Objective To determine whether endogenous testosterone has a causal role in
thromboembolism, heart failure, and myocardial infarction. Design Two sample mendelian …

Context Decades-old beliefs regarding androgens and prostate cancer (PCa) have
undergone dramatic shifts in light of modern evidence and new theoretical constructs, but …

Objective To review and quantify the association between endogenous and exogenous
testosterone and prostate‐specific antigen (PSA) and prostate cancer. Methods Literature …

Objective This study analyzed the effects of normalization of serum testosterone (T) levels on
anthropometric parameters in hypogonadal men. Design and Methods Open‐label, single …